Response to Measles, Mumps and Rubella (MMR) Vaccine in Transfusion-Dependent Patients

Response to Measles, Mumps and Rubella (MMR) Vaccine in Transfusion-Dependent Patients

Measles, mumps and rubella (MMR) still determine significant morbidity and mortality, although a highly effective vaccine is available. Postponing the MMR vaccination until 6 months after the last red blood cell (RBC) transfusion is recommended, but this delay is incompatible with chronic transfusio...

Full description

Bibliographic Details
Main Authors: Maddalena Casale, Nicoletta Di Maio, Valentina Verde, Saverio Scianguetta, Maria Grazia Di Girolamo, Rita Tomeo, Domenico Roberti, Saverio Misso, Silverio Perrotta
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Vaccines
Subjects:
transfusion
red blood cells
measles
mumps
rubella
live attenuated vaccine
Online Access:https://www.mdpi.com/2076-393X/9/6/561

Similar Items

Similar Items